Interacting Drugs |
Eltrombopag vs OATP1B1/SLCO1B1 Substrates |
Security Level |
 |
Mechanism |
OATP1B1/SLCO1B1 Substrates: Eltrombopag may increase the serum concentration of OATP1B1/SLCO1B1 Substrates. |
Management |
According to eltrombopag prescribing information, consideration of a preventative dose reduction may be warranted. |
Eltrombopag vs OATP1B1/SLCO1B1 Substrates
Post Review about Eltrombopag vs OATP1B1/SLCO1B1 Substrates Click here to cancel reply.
Other Interactions of Eltrombopag
Other Interactions of OATP1B1/SLCO1B1 Substrates
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.